好像是终止了一项重要试验。另外从纳斯达克
ScottS
2018-04-19
$Argos Therapeutics, Inc.(ARGS)$
好像是终止了一项重要试验。另外从纳斯达克转到了其他市场。
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
ScottS
2018-04-19
ScottS
机器翻译的,有点不通顺,姑且看看。
ScottS
2018-04-19
ScottS
April 19, 2018 08:00ET|Source:Argos Therapeutics, Inc.
- Company to terminate the ADAPT study –
- Company has retained Stifel to provide advice on possible strategic alternatives –
- Trading in the
ScottS
2018-04-19
ScottS
Trading in the common stock to be transferred from Nasdaq to the OTCQB Venture Market -
DURHAM, N.C., April 19, 2018
培源
2018-04-19
培源
转到其他市场,那我们是不是不能交易了?
什么也没有了~
APP内打开
发表看法
4
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":179590,"tweetId":"179590","gmtCreate":1524146589699,"gmtModify":1704891848472,"author":{"id":3467930283919797,"idStr":"3467930283919797","authorId":3467930283919797,"authorIdStr":"3467930283919797","name":"ScottS","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.laohu8.com/7333b0632e67129241522b6b3508e23f"},{"img":"https://static.laohu8.com/1949a2d88dcb6cf661fba49ee531c2b5"},{"img":"https://static.laohu8.com/3294794e12d8a40577a867391cfebbd3"},{"img":"https://static.laohu8.com/9eb38dcb2d78abac62594ce385aad501"}],"coverImages":[{"img":"https://static.laohu8.com/7333b0632e67129241522b6b3508e23f"},{"img":"https://static.laohu8.com/1949a2d88dcb6cf661fba49ee531c2b5"},{"img":"https://static.laohu8.com/3294794e12d8a40577a867391cfebbd3"}],"title":"好像是终止了一项重要试验。另外从纳斯达克","extraTitle":"","html":"<html><head></head><body><p></p> <p> </p> <img src=\"https://static.laohu8.com/9eb38dcb2d78abac62594ce385aad501\"> <p> </p> <p> </p> <p> </p> <img src=\"https://static.laohu8.com/1949a2d88dcb6cf661fba49ee531c2b5\"> <p> </p> <p>$Argos Therapeutics, Inc.(ARGS)$ </p> <p> </p> <img src=\"https://static.laohu8.com/7333b0632e67129241522b6b3508e23f\"> <p>好像是终止了一项重要试验。另外从纳斯达克转到了其他市场。 </p> <p> </p> <img src=\"https://static.laohu8.com/3294794e12d8a40577a867391cfebbd3\"> <p> </p> <p> </p></body></html>","htmlText":"<html><head></head><body><p></p> <p> </p> <img src=\"https://static.laohu8.com/9eb38dcb2d78abac62594ce385aad501\"> <p> </p> <p> </p> <p> </p> <img src=\"https://static.laohu8.com/1949a2d88dcb6cf661fba49ee531c2b5\"> <p> </p> <p>$Argos Therapeutics, Inc.(ARGS)$ </p> <p> </p> <img src=\"https://static.laohu8.com/7333b0632e67129241522b6b3508e23f\"> <p>好像是终止了一项重要试验。另外从纳斯达克转到了其他市场。 </p> <p> </p> <img src=\"https://static.laohu8.com/3294794e12d8a40577a867391cfebbd3\"> <p> </p> <p> </p></body></html>","text":"$Argos Therapeutics, Inc.(ARGS)$ 好像是终止了一项重要试验。另外从纳斯达克转到了其他市场。","highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":4,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/179590","repostId":0,"isVote":1,"tweetType":1,"viewCount":4238,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ARGS"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":84,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":724943,"commentId":"724943","gmtCreate":1524146714894,"gmtModify":1524146714894,"authorId":3467930283919797,"author":{"id":3467930283919797,"idStr":"3467930283919797","authorId":3467930283919797,"name":"ScottS","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":179590,"objectIdStr":"179590","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"机器翻译的,有点不通顺,姑且看看。","text":"机器翻译的,有点不通顺,姑且看看。","html":"机器翻译的,有点不通顺,姑且看看。","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":724970,"commentId":"724970","gmtCreate":1524147355660,"gmtModify":1524147355660,"authorId":3467930283919797,"author":{"id":3467930283919797,"idStr":"3467930283919797","authorId":3467930283919797,"name":"ScottS","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":179590,"objectIdStr":"179590","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"April 19, 2018 08:00ET|Source:Argos Therapeutics, Inc.\n<br>\n<br>- Company to terminate the ADAPT study –\n<br>\n<br>- Company has retained Stifel to provide advice on possible strategic alternatives –\n<br>\n<br>- Trading in the","text":"April 19, 2018 08:00ET|Source:Argos Therapeutics, Inc.\n<br>\n<br>- Company to terminate the ADAPT study –\n<br>\n<br>- Company has retained Stifel to provide advice on possible strategic alternatives –\n<br>\n<br>- Trading in the","html":"April 19, 2018 08:00ET|Source:Argos Therapeutics, Inc.\n<br>\n<br>- Company to terminate the ADAPT study –\n<br>\n<br>- Company has retained Stifel to provide advice on possible strategic alternatives –\n<br>\n<br>- Trading in the","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":724973,"commentId":"724973","gmtCreate":1524147421115,"gmtModify":1524147421115,"authorId":3467930283919797,"author":{"id":3467930283919797,"idStr":"3467930283919797","authorId":3467930283919797,"name":"ScottS","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":179590,"objectIdStr":"179590","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Trading in the common stock to be transferred from Nasdaq to the OTCQB Venture Market -\n<br>\n<br>DURHAM, N.C., April 19, 2018","text":"Trading in the common stock to be transferred from Nasdaq to the OTCQB Venture Market -\n<br>\n<br>DURHAM, N.C., April 19, 2018","html":"Trading in the common stock to be transferred from Nasdaq to the OTCQB Venture Market -\n<br>\n<br>DURHAM, N.C., April 19, 2018","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":724949,"commentId":"724949","gmtCreate":1524146845187,"gmtModify":1524146845187,"authorId":3474515369955493,"author":{"id":3474515369955493,"idStr":"3474515369955493","authorId":3474515369955493,"name":"培源","avatar":"https://static.tigerbbs.com/0c444b76a468ebc72db3ef9767716da1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":179590,"objectIdStr":"179590","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"转到其他市场,那我们是不是不能交易了?","text":"转到其他市场,那我们是不是不能交易了?","html":"转到其他市场,那我们是不是不能交易了?","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/179590"}
精彩评论
- Company to terminate the ADAPT study –
- Company has retained Stifel to provide advice on possible strategic alternatives –
- Trading in the
DURHAM, N.C., April 19, 2018